Stati Uniti - Ingliż - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405-6185 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/ risk summary published prospective cohort studies, case series, and case reports over several decades with trazodone hydrochloride use in pregnant women have not identified any drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see data). trazodone hydrochloride has been shown to cause increased fetal resorption and other adverse effects on the fetus in the rat when given at dose levels approximat

Stati Uniti - Ingliż - NLM (National Library of Medicine)

american health packaging - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 100 mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

seroyal usa - passiflora incarnata flowering top (unii: clf5yfs11o) (passiflora incarnata flowering top - unii:clf5yfs11o), ipomoea purga root (unii: 4udo46ybk2) (ipomoea purga root - unii:4udo46ybk2), arabica coffee bean (unii: 3sw678mx72) (arabica coffee bean - unii:3sw678mx72), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), palladium (unii: 5twq1v240m) (palladium - unii:5twq1v240m), tellurium (unii: nqa0o090zj) (tellurium - unii:nqa0o090zj), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - uni - passiflora incarnata flowering top 3 [hp_x] in 30 ml - uses for the temporary relief of symptoms associated with irregular sleep patterns ordinary restlessness uses for the temporary relief of symptoms associated with irregular sleep patterns ordinary restlessness directions to be taken ten minutes away from food. invert bottle and shake lightly allowing drops to fall directly under the tongue or into ¼ oz of water. hold contents for about 20 seconds and swallow. to promote drop flow, invert bottle and shake before each use. dosage frequency may be increased up to six times daily depending on the severity of symptoms. adults and adolescents (12 years and older) take 10 drops three times daily or as recommended by your healthcare practitioner. children (under 12 years) take under the direction of your healthcare practitioner.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride tablets usp are indicated for the treatment of major depressive disorder (mdd) in adults. the efficacy of trazodone hydrochloride tablets has been established in trials with the immediate release formulation of trazodone [see clinical studies (14) ]. none. pregnancy category c trazodone hydrochloride has been shown to cause increased fetal resorption and other adverse effects on the fetus in two studies using the rat when given at dose levels approximately 30 to 50 times the proposed maximum human dose. there was also an increase in congenital anomalies in one of three rabbit studies at approximately 15 to 50 times the maximum human dose. there are no adequate and well-controlled studies in pregnant women. trazodone hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. trazodone and/or its metabolites have been found in the milk of lactating rats, suggesting that the drug may be secreted in human milk. caution should b

Stati Uniti - Ingliż - NLM (National Library of Medicine)

a-s medication solutions - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: • patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. teratogenic effects pregnancy category c trazodone hydrochloride has been shown to cause increased fetal resorption and other adverse effects on the fetus in the rat when given at dose levels approximately 6 to 9 times the maximum recommended human dose (mrhd) of 400 mg/day on mg/m2 in adolescents. there was also an increase in congenital anomalies in the rabbit at approximately 6 to 17 times the mrhd on mg/m2 basis in adolescents. there are no adequate and well-controlled studies in pregnant women. trazodone hydrochloride should be used during pregnancy only if the potential benefi

Stati Uniti - Ingliż - NLM (National Library of Medicine)

cardinal health - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405- 6185 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/ risk summary published prospective cohort studies, case series, and case reports over several decades with trazodone use in pregnant women have not identified any drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see data). trazodone hydrochloride has been shown to cause increased fetal resorption and other adverse effects on the fetus in the rat when given at dose levels approximately 7.3 to 11

Stati Uniti - Ingliż - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - ipomoea purga root (unii: 4udo46ybk2) (ipomoea purga root - unii:4udo46ybk2) - colic, diarrhea condition listed above or as directed by the physician

Stati Uniti - Ingliż - NLM (National Library of Medicine)

natural health supply - ipomoea purga root (unii: 4udo46ybk2) (ipomoea purga root - unii:4udo46ybk2) - indications: to be used for acute self-limiting conditions according to standard homeopathic indications purpose: colic diarrhea

Stati Uniti - Ingliż - NLM (National Library of Medicine)

boiron - ipomoea purga root (unii: 4udo46ybk2) (ipomoea purga root - unii:4udo46ybk2) - children's diarrhea or colic* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

Stati Uniti - Ingliż - NLM (National Library of Medicine)

san’up - passiflora incarnata flowering top (unii: clf5yfs11o) (passiflora incarnata flowering top - unii:clf5yfs11o), arabica coffee bean (unii: 3sw678mx72) (arabica coffee bean - unii:3sw678mx72), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), ipomoea purga root (unii: 4udo46ybk2) (ipomoea purga root - unii:4udo46ybk2), palladium (unii: 5twq1v240m) (palladium - unii:5twq1v240m), tellurium (unii: nqa0o090zj) (t - uses for the temporary relief of symptoms associated with irregular sleep patterns and ordinary restlessness. uses for the temporary relief of symptoms associated with irregular sleep patterns and ordinary restlessness. product ‘uses’ are based on homeopathic materia medica and are not supported by clinical trials. these 'uses' have not been evaluated by the food and drug administration. directions to be taken 10 minutes away from food. invert bottle and shake lightly allowing drops to fall directly under the tongue or into ¼ oz of water. hold contents for about 20 seconds and swallow. to promote drop flow, invert bottle and shake before each use. dosage frequency may be increased up to 6 times daily depending on the severity of symptoms. adults and adolescents (12 years and older) take 10 drops 3 times daily or as recommended by your healthcare practitioner. children (under 12 years) .take under the direction of your healthcare practitioner. stop use and ask a doctor if symptoms persist or worsen.